1. Katzmann, Julius L, Cupido, Arjen J, Laufs, Ulrich. 2022. Gene Therapy Targeting PCSK9. In Metabolites, 12, . doi:10.3390/metabo12010070. https://pubmed.ncbi.nlm.nih.gov/35050192/
2. Liu, Xinjian, Bao, Xuhui, Hu, Mengjie, Li, Fang, Li, Chuan-Yuan. 2020. Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer. In Nature, 588, 693-698. doi:10.1038/s41586-020-2911-7. https://pubmed.ncbi.nlm.nih.gov/33177715/
3. Li, Yan-Yan, Wang, Hui, Yang, Xin-Xing, Gong, Ge, Lu, Xin-Zheng. 2020. PCSK9 Gene E670G Polymorphism and Coronary Artery Disease: An Updated Meta-Analysis of 5,484 Subjects. In Frontiers in cardiovascular medicine, 7, 582865. doi:10.3389/fcvm.2020.582865. https://pubmed.ncbi.nlm.nih.gov/33244470/
4. Katzmann, Julius L, Laufs, Ulrich. 2024. PCSK9-directed therapies: an update. In Current opinion in lipidology, 35, 117-125. doi:10.1097/MOL.0000000000000919. https://pubmed.ncbi.nlm.nih.gov/38277255/
5. Zhuang, Junli, Zhu, Hua, Cheng, Ziqi, Xiong, Xiaoxing, Deng, Hongping. 2023. PCSK9, a novel immune and ferroptosis related gene in abdominal aortic aneurysm neck. In Scientific reports, 13, 6054. doi:10.1038/s41598-023-33287-9. https://pubmed.ncbi.nlm.nih.gov/37055467/
6. Musunuru, Kiran, Chadwick, Alexandra C, Mizoguchi, Taiji, Bellinger, Andrew M, Kathiresan, Sekar. 2021. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. In Nature, 593, 429-434. doi:10.1038/s41586-021-03534-y. https://pubmed.ncbi.nlm.nih.gov/34012082/
智鼠故事 
